mortality rates. Outcomes in TOLAC have often been explored in populations with low TOLAC rates, and some of these studies have included women delivering in academic centers only. [8] [9] [10] Often, a policy of repeat CS by maternal request has been followed. 11, 12 Thus, the interpretation and comparison of results have been difficult.
In Norway, between 1989-2009 a TOLAC rate of 70% has been observed in cephalic single pregnancies with a gestation age of 37 weeks or more (Lehmann, Irgens, Baghestan, Børdahl and Rasmussen; personal communication, unpublished data.). The resulting rate of vaginal birth after CS was 53%, which is in the same range as in Finland, Sweden, and the Netherlands. Other European countries and the USA have considerably lower rates of TOLAC and vaginal birth after CS. 6, 10, 13 Findings in previous studies of perinatal outcome in TOLAC do not necessarily apply in settings with high rates of TOLAC. A practice with a high rate of TOLAC warrants adequate surveillance of outcomes, especially in high-risk deliveries. Thus, the objective of the study was to compare perinatal outcomes in TOLAC and non-TOLAC in Norway, 1989 Norway, -2009 , stratified by risk. The validity of Medical Birth Registry of Norway data for identification of TOLAC was assessed in a separate study, and found acceptable. 4 The outcome variables were offspring mortality, 5-minute Apgar score < 7 and < 4, transfer to a neonatal intensive care unit (NICU), and neonatal respiratory distress syndrome diagnosed by a pediatrician. Offspring mortality was defined as offspring death during delivery (n = 6), first 28 days of life (n = 60), time of death unknown (n = 18), and pre-labor stillbirths delivered after 39 weeks of gestation (n = 46). Pre-labor stillbirths in week 37 to 38 (n = 14) were not included in the definition, since this outcome occurs before a planned CS is usually performed.
| MATERIAL AND ME THODS
All stillbirths (n = 84) were excluded from the analyses of 5-minute Apgar scores < 7, and < 4, NICU transfer, and neonatal respira- (total annual number of deliveries, ≤ 499, 500-1499, 1500-2999, and ≥ 3000).
Number needed to treat for offspring mortality, ie the number of planned CSs necessary to perform to avoid one offspring death, was calculated using a 95% CI based on the mortality rate reduction. 15 In the high-risk group we also performed supplementary analyses of mortality excluding cases with major malformations (n = 1086).
General characteristics of the study population are provided in Table 1 .
Key Message
With a trial of labor rate of 70%, we observed higher risk of offspring mortality and low 5-minute Apgar score in trial of labor, compared to planned cesarean section.
F I G U R E 1 Flow charts indicating inclusion and exclusion criteria and completeness of outcome data in the analyses of mortality, 5-min Apgar score, transfer to a neonatal intensive care unit (NICU), and neonatal respiratory distress syndrome (NRDS). 
Five minute Apgar score NICU transfer and NRDS
In the calculation of RR and adjusted RR, we used SPSS version 20.0 (IBM, Armonk, NY, USA). In the calculation of the number needed to treat we used a free online spreadsheet.
| Ethical approval
The study was approved by the Regional Ethics Committee (REK Vest case no. 2012/1466).
| RE SULTS
The offspring mortality rate (Table 2) Thus, the absolute risk reduction was 2.4/1000 in non-TOLAC, and the number of planned CSs needed to avoid one offspring death was 420 (289-766). In low-risk pregnancies the rate was 2.3/1000 in TOLAC TA B L E 1 Characteristics of the study groups; trial of labor (TOLAC), non-TOLAC and unclassifiable deliveries, second deliveries after a first delivery cesarean section, Norway 1989-2009 (single gestation, gestational age > 37 wk, cephalic presentation) The 5-minute Apgar score < 4 rate was 2.6/1000 in TOLAC compared with 0.9/1000 in non-TOLAC, with an adjusted RR of 2.88
(1.50-5.54) ( Table 3 ). In low-risk pregnancies the rate was 2.1/1000 in TOLAC compared with 0.9/1000 in non-TOLAC, with an adjusted RR of 2.67 (0.93-7.71). In high-risk pregnancies the rate was 3.1/1000 in TOLAC compared with 0.9/1000 in non-TOLAC, with an adjusted RR of 3.32 (1.46-7.55).
The 5-minute Apgar score rate < 7 was 13.3/1000 in TOLAC compared with 4.4/1000 in non-TOLAC, with an adjusted RR of 3.07 (2.30-4.10) ( Table 3 ). In low-risk pregnancies, the rate was 10.8/1000
in TOLAC compared with 4.1/1000 in non-TOLAC, with an adjusted TA B L E 2 Mode of delivery specific offspring mortality* in trial of labor section (TOLAC), after cesarean, non-TOLAC and unclassifiable, in second deliveries after a first delivery cesarean section, Norway 1989-2009. Number of cases (n), incidence rate (n/1000), relative risk (RR), and relative risk adjusted for year of delivery, maternal age, education, country of origin, hospital size, and health region (adjusted RR) In both low-risk and high-risk pregnancies risks of adverse outcomes were higher in TOLAC failure than in vaginal TOLAC deliveries. The unclassified deliveries had a consistent higher risk of adverse outcomes than the classified deliveries (Tables 2-4 ).
| D ISCUSS I ON
In TOLAC deliveries, a higher offspring mortality was observed irrespective of the risk group. In the high-risk deliveries, a higher of 5-minute Apgar score < 4 was observed. In both risk groups, a 5-minute Apgar score < 7 was more frequent in TOLAC. No difference was observed regarding transfer to a NICU. Non-TOLAC was associated with neonatal respiratory distress syndrome. The risk of adverse outcome in TOLAC pertained to TOLAC failure.
The strengths of the study include the large number of pregnancies, the population-based design, and the use of validated data. 4 The data allowed adjustment for confounders and stratification by risk. The definition of the high-risk group was based on clinical assessment prior to onset of the delivery. The low-risk group was defined to exclude preexisting conditions that had a potential to aggravate the outcomes. However, some residual medical risk due to incomplete registration and diagnostics cannot be ruled out.
Further, in 974 deliveries the data did not suffice for classification as TOLAC or non-TOLAC. It seems that approximately 50% of these unclassifiable deliveries represent true TOLAC failure and 50%
of true non-TOLAC. 4 The mortality in this group was high (11/974), possibly due to the less complete notification after an adverse outcome. Another possibility is that the absence of a recorded plan in the Medical Birth Registry of Norway data represents an actual lack of pre-delivery planning with an ensuing less favorable prognosis. A disproportionate distribution of adverse outcomes in the unclassifiable deliveries may cause bias in the estimation of risks attributable to TOLAC compared with non-TOLAC.
Having had a previous CS has been associated with higher risk of pre-labor fetal stillbirth. 16, 17 Thus, the expectant management involved in a TOLAC might cause higher risk of intrauterine fetal death compared than a planned CS, since a planned CS is usually Comparison of studies is hampered by differences in approach, inclusion criteria, and, if present, differences in risk stratification. 6 In a UK registry-based study and review, Moraitis et al reported there
was an higher risk of pre-labor stillbirth after a previous CS with a hazard ratio of 1.4, compared with pregnancies after a previous vaginal birth. 7 Due to differences in design, a comparable hazard ratio in our study cannot be obtained.
Excluding pre-labor stillbirths, the higher mortality observed in TOLAC compared with non-TOLAC is in accordance with previous research. 8, 11, 12 In a review of studies in developed countries, a pooled neonatal mortality (0-28 days) of 0.11% has been reported in TOLAC compared with 0.06% in non-TOLAC, 6 This agrees well with 0.18% and 0.09% mortality in the present study, which also included deaths during labor and stillbirths with an unknown time of death.
In a risk-stratified US study with a TOLAC rate of 28.5% in lowrisk pregnancies, a neonatal mortality rate of 0.13% was reported in TOLAC, compared with 0.05% in non-TOLAC. 18 This agrees with the 0.12% vs 0.09% mortality rate observed in low-risk pregnancies in our study after excluding pre-labor stillbirths. In high risk pregnancies the US study reported a 25.8% TOLAC rate, with a neonatal mortality rate of 0.38%, compared with 0.10% in non-TOLAC, which also agrees with our findings of 0.25% in TOLAC and 0.09% in non-TOLAC, also excluding pre-labor stillbirths. 18 Unlike our study, several previous studies have reported no difference between TOLAC and non-TOLAC regarding the 5-minute Apgar score. 19, 20 However, a UK registry-based study observed higher risk of 5-minute Apgar score < 4 in the TOLAC group; that is, 0.68% compared with 0.44% in non-TOLAC. 21 A Swedish population-based study reported a 5-minute Apgar score < 7 in 1.8% of TOLAC deliveries vs 1.1% in non-TOLAC.
22
A recent Danish study of women eligible for TOLAC, including some risk conditions that were not present in our low-risk group, also reported a 5-minute Apgar score < 7 or a blood sample pH < 7 in 1.8% of TOLAC cases, compared with 0.5% of non-TOLAC cases. 12 Obtained in deliveries comprising maternal choice, this agrees with our findings in low-risk pregnancies. A low Apgar score at 5 minutes after delivery has been associated with a longterm health impairment. 21, 23, 24 In the present study, after adjustment a reduced risk of NICU transfer was observed in TOLAC compared with non-TOLAC. Most previous research appears to support the view that the risk of NICU transfer in TOLAC deliveries is not higher than in non-TOLAC. 10 However The induction rate in TOLAC in the present study was 21% (all methods). The high-risk group was heterogeneous and comprised several conditions in which induction might be indicated, eg diabetes type I. Induction is a well-known risk factor for intrapartum complications in TOLAC, 27 and might explain some of the higher risk observed in TOLAC in the high-risk group. The risks and benefits of induction compared with the planned CS in such cases should be further studied.
The mortality observed in TOLAC consisted of two elements: prelabor stillbirth after 39 weeks' gestational age and deaths occurring after a TOLAC has been started. With the observed number needed to treat, 420 (289-766), a practice of planned CS at 39 weeks of gestation as a potentially lifesaving intervention may appear reasonable. On the other hand, this comes at the cost of higher maternal morbidity and mortality, as well as more respiratory morbidity in the offspring. 6 A risk of pre-labor stillbirth is also present in uncomplicated pregnancies without a previous CS. 28 The additional risk conferred by a previous CS has been debated and the causes are incompletely understood. 7 Thus, it is unclear what impact a lower TOLAC rate may have on the overall mortality rate. Nevertheless, in the clinical choice between TOLAC and non-TOLAC, the risk of a pre-labor stillbirth after 39 weeks of gestational age should be considered.
For both risk groups studied, the highest rates of adverse out- 
| CON CLUS ION
The higher risk of offspring mortality and reduced Apgar score observed in TOLAC after CS compared to non-TOLAC warrants caution in planning and delivery care. This applies to high-risk pregnancies in particular, balancing this against the higher risk of neonatal respiratory distress syndrome and maternal morbidity associated with non-TOLAC. Subgroups and practice patterns should be further studied to identify specific risk factors and possible preventive measures.
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